Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
C174237-5mg | 5mg | In stock | $44.90 | |
C174237-10mg | 10mg | In stock | $68.90 | |
C174237-25mg | 25mg | In stock | $121.90 | |
C174237-50mg | 50mg | In stock | $210.90 | |
C174237-100mg | 100mg | In stock | $350.90 | |
C174237-250mg | 250mg | In stock | $701.90 |
Synonyms | A14396 | BCP28287 | FT-0767818 | U6CL98GLP4 | A857288 | EX-A1310 | MFCD28167826 | AS-75090 | HMS3873G13 | NCGC00356145-11 | WHO 10815 | 1439399-58-2 | 2-Pyridineacetamide, N-(5-(4-(6-((2-(3-(trifluoromethoxy)phenyl)acetyl)amino)-3-pyridazinyl)butyl)-1,3,4 |
---|---|
Specifications & Purity | Moligand™, ≥98% |
Storage Temp | Protected from light,Store at -20°C,Argon charged |
Shipped In | Ice chest + Ice pads |
Grade | Moligand™ |
Action Type | INHIBITOR |
Mechanism of action | Glutaminase kidney isoform, mitochondrial inhibitor |
Product Description | Biochemical mechanism: Cell permeable: yes Primary Target GLS1 Reversible: yes Target IC50: 23 nM & 28 nM, respectively, using murine kidney and brain homogenates |
ALogP | 3.6 |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Pubchem Sid | 488202265 |
---|---|
Pubchem Sid Url | https://pubchem.ncbi.nlm.nih.gov/substance/488202265 |
IUPAC Name | N-[6-[4-[5-[(2-pyridin-2-ylacetyl)amino]-1,3,4-thiadiazol-2-yl]butyl]pyridazin-3-yl]-2-[3-(trifluoromethoxy)phenyl]acetamide |
INCHI | InChI=1S/C26H24F3N7O3S/c27-26(28,29)39-20-9-5-6-17(14-20)15-22(37)31-21-12-11-18(33-34-21)7-1-2-10-24-35-36-25(40-24)32-23(38)16-19-8-3-4-13-30-19/h3-6,8-9,11-14H,1-2,7,10,15-16H2,(H,31,34,37)(H,32,36,38) |
InChi Key | PRAAPINBUWJLGA-UHFFFAOYSA-N |
Canonical SMILES | C1=CC=NC(=C1)CC(=O)NC2=NN=C(S2)CCCCC3=NN=C(C=C3)NC(=O)CC4=CC(=CC=C4)OC(F)(F)F |
Isomeric SMILES | C1=CC=NC(=C1)CC(=O)NC2=NN=C(S2)CCCCC3=NN=C(C=C3)NC(=O)CC4=CC(=CC=C4)OC(F)(F)F |
PubChem CID | 71577426 |
Molecular Weight | 571.57 |
PubChem CID | 71577426 |
---|---|
BindingDB Ligand | 109086 |
CAS Registry No. | 1439399-58-2 |
RCSB PDB Ligand | 63J |
PubChem SID | 488202265 |
Enter Lot Number to search for COA:
Find and download the COA for your product by matching the lot number on the packaging.
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
H2407268 | Certificate of Analysis | Jul 26, 2024 | C174237 |
H2407266 | Certificate of Analysis | Jul 26, 2024 | C174237 |
H2407263 | Certificate of Analysis | Jul 26, 2024 | C174237 |
H2407257 | Certificate of Analysis | Jul 26, 2024 | C174237 |
C2413219 | Certificate of Analysis | Feb 29, 2024 | C174237 |
C2413221 | Certificate of Analysis | Feb 29, 2024 | C174237 |
E2326646 | Certificate of Analysis | May 05, 2023 | C174237 |
E2326652 | Certificate of Analysis | May 05, 2023 | C174237 |
E2326651 | Certificate of Analysis | May 05, 2023 | C174237 |
E2326650 | Certificate of Analysis | May 05, 2023 | C174237 |
E2326648 | Certificate of Analysis | May 05, 2023 | C174237 |
E2326647 | Certificate of Analysis | May 05, 2023 | C174237 |
E2326645 | Certificate of Analysis | May 05, 2023 | C174237 |
E2326642 | Certificate of Analysis | May 05, 2023 | C174237 |
E2326639 | Certificate of Analysis | May 05, 2023 | C174237 |
A2213147 | Certificate of Analysis | Nov 30, 2021 | C174237 |
A2213151 | Certificate of Analysis | Nov 30, 2021 | C174237 |
A2213150 | Certificate of Analysis | Nov 30, 2021 | C174237 |
A2213149 | Certificate of Analysis | Nov 30, 2021 | C174237 |
A2213148 | Certificate of Analysis | Nov 30, 2021 | C174237 |
Solubility | Chloroform (Slightly, Sonicated), DMSO (Slightly, Sonicated), Methanol (Slightly |
---|---|
Sensitivity | light sensitive |
Melt Point(°C) | 186- 189° C |
Starting at $59.90
1. Gross MI, Demo SD, Dennison JB, Chen L, Chernov-Rogan T, Goyal B, Janes JR, Laidig GJ, Lewis ER, Li J et al.. (2014) Antitumor activity of the glutaminase inhibitor CB-839 in triple-negative breast cancer.. Mol Cancer Ther, 13 (4): (890-901). [PMID:24523301] |